Tingting Wang PhD Eli Lilly and Company

Tingting Wang is currently a Sr. Director in the Department of Bioproduct Research and Development at Eli Lilly and Company. She earned her Bachelor of Science at Jilin University, China, and her PhD in Chemistry from the University of Wisconsin-Madison. Dr. Tingting Wang finished her Post-Doc work in Macromolecule and Vaccine Stabilization Center at the University of Kansas and worked for Novartis and GSK on large molecule formulation development before joining Eli Lilly and Company. She has been working for the Eli Lilly formulation team for more than 8 years. Dr. Wang's team at Eli Lilly is responsible for formulation development and process development of parenteral formulations, including biologics and synthetic molecules. Dr. Tingting Wang has a strong scientific interest and contribution in the area of surfactant application in large molecule formulation and interactions between drug products and container/closure systems.